コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 also be considered in the workup of neonatal hemolytic uremic syndrome.
2 ient experienced fatal chronic rejection and hemolytic uremic syndrome.
3 thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.
4 EHEC causes severe bloody diarrhea and hemolytic uremic syndrome.
5 ated macular degeneration (AMD) and atypical hemolytic uremic syndrome.
6 se vascular and renal injury and can trigger hemolytic uremic syndrome.
7 es; 67% were hospitalized and 6.4% developed hemolytic uremic syndrome.
8 r several renal diseases, including atypical hemolytic uremic syndrome.
9 been described in association with atypical hemolytic uremic syndrome.
10 eadly thrombomicroangiopathy called atypical hemolytic uremic syndrome.
11 in hemorrhagic colitis and life-threatening hemolytic uremic syndrome.
12 thrombotic microangiopathy disease, atypical hemolytic uremic syndrome.
13 and travelers' diarrhea, gastroenteritis and hemolytic uremic syndrome.
14 to severe diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome.
15 e systemic (pathological) effects, including hemolytic uremic syndrome.
16 ne gastroenteritis, hemorrhagic colitis, and hemolytic uremic syndrome.
17 ng defects in complement regulation, such as hemolytic uremic syndrome.
18 cherichia coli cause hemorrhagic colitis and hemolytic uremic syndrome.
19 Three patients had reversible hemolytic uremic syndrome.
20 ogen that causes hemorrhagic colitis and the hemolytic uremic syndrome.
21 a, hemorrhagic colitis, and life-threatening hemolytic uremic syndrome.
22 plicated in cases of hemorrhagic colitis and hemolytic uremic syndrome.
23 e kidneys, coincidental with the symptoms of hemolytic uremic syndrome.
24 ficiency of CD46 is a predisposing factor to hemolytic uremic syndrome.
25 nal disease and the life-threatening sequela hemolytic uremic syndrome.
26 rence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
27 xysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
28 renal coagulation and thrombosis observed in hemolytic uremic syndrome.
29 Escherichia coli (STEC) are associated with hemolytic uremic syndrome.
30 acute kidney failure in children who develop hemolytic uremic syndrome.
31 aging findings in a four-month-old male with hemolytic uremic syndrome.
32 induced by sera from patients with atypical hemolytic uremic syndrome.
33 renal biopsy of a child with EHEC-associated hemolytic uremic syndrome.
34 sease, including hemorrhagic colitis and the hemolytic uremic syndrome.
35 nary tract infections, as well as sepsis and hemolytic uremic syndrome.
36 mplications, such as hemorrhagic colitis and hemolytic uremic syndrome.
37 rne pathogen causing hemorrhagic colitis and hemolytic uremic syndrome.
38 infection, and disseminated malignancy or in hemolytic uremic syndrome.
39 with eculizumab after a relapse of atypical hemolytic uremic syndrome.
40 okine, interleukin-1beta, has been linked to hemolytic uremic syndrome.
41 pathogen that causes hemorrhagic colitis and hemolytic uremic syndrome.
42 -1 cells, an experimental model for atypical hemolytic uremic syndrome.
43 d in the development of the life-threatening hemolytic uremic syndrome.
44 ylglycerol kinase epsilon result in atypical hemolytic-uremic syndrome.
45 an illnesses such as hemorrhagic colitis and hemolytic-uremic syndrome.
46 cause severe clinical manifestations such as hemolytic-uremic syndrome.
47 li O157:H7 (EHEC) causes bloody diarrhea and hemolytic-uremic syndrome.
48 al prophylactic or therapeutic agent against hemolytic-uremic syndrome.
49 f hemorrhagic colitis and, less commonly, to hemolytic-uremic syndrome.
50 , causing diarrhea, hemorrhagic colitis, and hemolytic-uremic syndrome.
51 ients were hospitalized and 2 (9%) developed hemolytic-uremic syndrome.
52 t cause of mortality among patients with the hemolytic-uremic syndrome.
53 ogen and is the cause of bloody diarrhea and hemolytic-uremic syndrome.
54 rrhagic colitis that sometimes progresses to hemolytic-uremic syndrome.
55 /14) with O157 strains (P = 0.03) developing hemolytic-uremic syndrome.
56 pathophysiology of neuronal complications in hemolytic-uremic syndrome.
57 in renal function in patients with atypical hemolytic-uremic syndrome.
58 ), portal vein thrombosis (1), priapism (1), hemolytic uremic syndrome (1), diaphragm perforation (2)
59 E. coli have been reported--3167 without the hemolytic-uremic syndrome (16 deaths) and 908 with the h
60 uremic syndrome (16 deaths) and 908 with the hemolytic-uremic syndrome (34 deaths)--indicating that t
62 tations in FH and MCP are linked to atypical hemolytic uremic syndrome, a type of thrombotic microang
63 e development of colitis and/or signs of the hemolytic uremic syndrome after oral infection with Esch
65 H) mutations predispose patients to atypical hemolytic uremic syndrome (aHUS) and other disorders ari
66 at is also causally associated with atypical hemolytic uremic syndrome (aHUS) and related glomerulopa
67 inhibition therapy in patients with atypical hemolytic uremic syndrome (aHUS) are remarkable in contr
68 in, have been well characterized in atypical hemolytic uremic syndrome (aHUS) but have been less well
70 escribe an assay that could convert atypical hemolytic uremic syndrome (aHUS) from a diagnosis of exc
71 eneic HSCT shares similarities with atypical hemolytic uremic syndrome (aHUS) in the underlying patho
88 ions in complement C3 identified in atypical hemolytic uremic syndrome (aHUS) patients cause dysregul
89 he thrombotic microangiopathy (TMA) atypical hemolytic uremic syndrome (aHUS) resulted in the success
90 iseases C3 glomerulopathy (C3G) and atypical hemolytic uremic syndrome (aHUS) strongly associate with
91 by a lack of ADAMTS13 activity, and atypical hemolytic uremic syndrome (aHUS), a disease of complemen
92 ave been described in patients with atypical hemolytic uremic syndrome (aHUS), a rare condition chara
94 h was described in association with atypical hemolytic uremic syndrome (aHUS), also confers high risk
95 related macular degeneration (AMD), atypical hemolytic uremic syndrome (aHUS), and membranoproliferat
96 ment genes reportedly contribute to atypical hemolytic uremic syndrome (aHUS), but incomplete penetra
98 ed CFH, whereas R53H-CFH, linked to atypical hemolytic uremic syndrome (aHUS), was defective in C3bBb
99 Complement dysregulation leads to atypical hemolytic uremic syndrome (aHUS), while ADAMTS13 deficie
105 to severe renal diseases, including atypical hemolytic uremic syndrome and C3 glomerulopathies, and a
106 arrhea and postdiarrheal sequelae, including hemolytic uremic syndrome and central nervous system (CN
107 associated with the renal diseases atypical hemolytic uremic syndrome and dense deposit disease and
108 th more severe disease, as defined by higher hemolytic uremic syndrome and hospitalization frequencie
109 ) has been implicated in the pathogenesis of hemolytic uremic syndrome and its attendant endothelial
110 ly members affected with late-onset atypical hemolytic uremic syndrome and symptoms of glomerulonephr
111 lation-mediated endothelial damage: atypical hemolytic uremic syndrome and thrombotic thrombocytopeni
114 g age-related macular degeneration, atypical hemolytic uremic syndrome, and C3 glomerulopathies.
115 e has been implicated previously in atypical hemolytic uremic syndrome, and it abrogates C-terminal l
116 e-specific diseases such as AMD and atypical hemolytic uremic syndrome, and leads to a better underst
118 atric systemic lupus erythematosus, atypical hemolytic uremic syndrome, and the complocentric membran
120 these genes have been described in atypical hemolytic uremic syndrome, arising commonly through nona
121 the basis of clinical presentation (atypical hemolytic uremic syndrome as thrombotic microangiopathy)
122 Compared with wild type FH19-20, atypical hemolytic uremic syndrome-associated mutants were less a
123 standing of the structural basis of familial hemolytic uremic syndrome, attributed to mutational disr
124 nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome, blocks the terminal complemen
125 ts infected with E. coli O157:H7 progress to hemolytic uremic syndrome, but this figure may reach 50%
126 Shiga toxin (Stx) causes diarrhea-associated hemolytic uremic syndrome by damaging renal microvascula
127 ombotic microangiopathies including atypical hemolytic uremic syndrome, C3 and C1q glomerulopathies,
135 atients, a serious but completely reversible hemolytic-uremic syndrome developed during the second cy
139 Escherichia coli causes diarrhea-associated hemolytic-uremic syndrome (DHUS), a severe renal thrombo
141 rence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome during pregnancy and (2) to se
142 afety of anticomplement therapy for atypical hemolytic uremic syndrome during pregnancy, and implicat
144 h preventive or therapeutic ends, for use in hemolytic uremic syndrome-endemic areas or during future
145 sorders, we have identified a large atypical hemolytic uremic syndrome family where a deletion has oc
146 eries of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome from 1964 to 2002 were reviewe
147 result in serious long-term sequelae such as hemolytic uremic syndrome, Guillain-Barre syndrome and m
149 ding thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome, have been reported to have a
150 types might influence the risk of developing hemolytic uremic syndrome (HUS) after Escherichia coli O
152 roup O also comprised 64.3% of patients with hemolytic uremic syndrome (HUS) and 87.5% of patients wh
153 (Stx1, Stx2) responsible for development of hemolytic uremic syndrome (HUS) and acute kidney injury
154 kidney damage is one of the major causes of hemolytic uremic syndrome (HUS) and acute renal failure
155 nd shares histomorphologic similarities with hemolytic uremic syndrome (HUS) and thrombotic thrombocy
156 hrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) are appropriately at the
157 botic thrombocytopenic purpura (TTP) and the hemolytic uremic syndrome (HUS) are both characterized b
158 EHEC) O157:H7 causes hemorrhagic colitis and hemolytic uremic syndrome (HUS) by colonizing the gut mu
159 TEC) serotypes associated with postdiarrheal hemolytic uremic syndrome (HUS) cases among children and
161 orted diarrhea or developed life-threatening hemolytic uremic syndrome (HUS) in any of 6 closed cohor
162 aper describes the epidemiology of childhood hemolytic uremic syndrome (HUS) in California, for which
163 104:H4 caused an outbreak with >800 cases of hemolytic uremic syndrome (HUS) in Germany, including 90
175 O104:H4) infection with a high incidence of hemolytic uremic syndrome (HUS) occurred in Germany in M
176 and June 2011 the largest known outbreak of hemolytic uremic syndrome (HUS) occurred in northern Ger
178 3%-15% of individuals the infection leads to hemolytic uremic syndrome (HUS) or other complications.
180 e offending agent of postdiarrhea-associated hemolytic uremic syndrome (HUS), a disorder of glomerula
181 li is a primary cause of diarrhea-associated hemolytic uremic syndrome (HUS), a disorder of thrombocy
182 li is the main etiological agent that causes hemolytic uremic syndrome (HUS), a microangiopathic dise
183 f often bloody diarrhea that can progress to hemolytic uremic syndrome (HUS), a systematic microvascu
184 tion status, the development and severity of hemolytic uremic syndrome (HUS), and adverse outcomes in
185 e progresses to hemorrhagic colitis (HC) and hemolytic uremic syndrome (HUS), due to the expression o
186 the alternative pathway, are associated with hemolytic uremic syndrome (HUS), membranoproliferative g
187 role in the pathogenesis of postenteropathic hemolytic uremic syndrome (HUS), most commonly caused by
188 colitis is complicated by potentially lethal hemolytic uremic syndrome (HUS), particularly in childre
189 eases, such as sickle cell disease (SCD) and hemolytic uremic syndrome (HUS), pathological biophysica
190 moxetumomab pasudotox for 10 doses developed hemolytic uremic syndrome (HUS), thrombotic microangiopa
209 ated with thrombotic microangiopathy are the hemolytic-uremic syndrome (HUS) and thrombotic thrombocy
210 oduce Shiga toxin 2 (Stx2) are isolated from hemolytic-uremic syndrome (HUS) cases more frequently th
213 roducing Escherichia coli (STEC) can lead to hemolytic-uremic syndrome (HUS) in 5 to 10% of patients.
214 ections can often lead to the development of hemolytic-uremic syndrome (HUS) in a small percentage of
223 e severe hemorrhagic colitis and can lead to hemolytic-uremic syndrome (HUS), a life-threatening cond
224 cherichia coli O157:H7 infection can lead to hemolytic-uremic syndrome (HUS), a severe disease charac
225 family of cytotoxic proteins that can cause hemolytic-uremic syndrome (HUS), a thrombotic microangio
226 i (STEC) strains are responsible for causing hemolytic-uremic syndrome (HUS), and systemic administra
228 producing systemic complications, including hemolytic-uremic syndrome (HUS), in animal models of dis
229 saa gene in STEC isolates from patients with hemolytic-uremic syndrome (HUS), patients with less seve
231 ions, including hemorrhagic colitis (HC) and hemolytic-uremic syndrome (HUS), which is the most commo
232 ntestinal effects of STEC infection, such as hemolytic-uremic syndrome (HUS), zinc might be capable o
244 ith Shiga toxin-producing E. coli-associated hemolytic uremic syndrome in six hospitals in Hamburg, G
247 li (STEC), a cause of food-borne colitis and hemolytic-uremic syndrome in children, can be serotype O
249 of regional outbreaks of bloody diarrhea and hemolytic-uremic syndrome in the United States and world
250 cin-injected mice developed the hallmarks of hemolytic uremic syndrome, including thrombotic microang
254 FHR) genes and autoantibody-positive form of hemolytic uremic syndrome is characterized by the presen
255 pment of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome is near term and during the po
260 sent in patients with the autoimmune form of hemolytic uremic syndrome, is involved in B cell regulat
262 xin 2 (Stx2), one of the causative agents of hemolytic-uremic syndrome, is toxic to endothelial cells
265 events was more frequent with everolimus and hemolytic uremic syndrome, lymphoproliferative disease,
266 -threatening sequela of infection called the hemolytic uremic syndrome may develop that can lead to k
267 hia coli O157:H7 causes severe enteritis and hemolytic-uremic syndrome, mostly in young children and
268 only serious toxicity was reversible grade 3 hemolytic uremic syndrome, not requiring plasmapheresis,
269 Escherichia coli serotype O104:H4-associated hemolytic uremic syndrome occurred in Northern Germany.
271 ith defective regulation of the AP (atypical hemolytic-uremic syndrome) or with inadequate cleavage b
273 laboratory-confirmed E coli O157 infection, hemolytic-uremic syndrome, or bloody diarrhea within 7 d
274 011 Shiga toxin-producing E. coli-associated hemolytic uremic syndrome outbreak in Germany, critical
275 samples from 19 anti-FH Ab-positive atypical hemolytic uremic syndrome patients collected at the acut
277 The results may also explain why atypical hemolytic uremic syndrome patients with mutations affect
278 chia coli pathophysiology and progression to hemolytic uremic syndrome provides the basis for prevent
281 ns associated with the related human disease hemolytic uremic syndrome) resulted in a striking syndro
282 ry 1983 to February 2001 using the key words hemolytic uremic syndrome, risk factor, antibiotics, and
287 a spectrum of rare diseases such as atypical hemolytic uremic syndrome, thrombotic thrombocytopenic p
289 nts with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) is difficult because
290 reported thrombotic thrombocytopenia purpura/hemolytic uremic syndrome (TTP/HUS) case involved a pati
291 establish treatment guidelines for atypical hemolytic uremic syndrome was held in Bergamo in Decembe
292 ith Shiga toxin-producing E. coli-associated hemolytic uremic syndrome were admitted to eight ICUs.
294 dney lesions similar to those in humans with hemolytic-uremic syndrome were observed histologically i
295 familial thrombotic thrombocytopenic purpura-hemolytic uremic syndrome who were initially diagnosed d
296 ase 2 trials in which patients with atypical hemolytic-uremic syndrome who were 12 years of age or ol
298 ratory abnormalities consistent with grade 2 hemolytic uremic syndrome with peak creatinine of 1.53 t
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。